Challenges of treating melanoma in situ, lentigo maligna type: is pathological clearance the gold standard?
- PMID: 28504388
- DOI: 10.1111/bjd.15512
Challenges of treating melanoma in situ, lentigo maligna type: is pathological clearance the gold standard?
Comment on
-
Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study.Br J Dermatol. 2017 May;176(5):1148-1154. doi: 10.1111/bjd.15112. Epub 2017 Apr 10. Br J Dermatol. 2017. PMID: 27714781 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
